Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Luke Eastburg"'
Publikováno v:
Pediatrics in Review. 44:283-285
Autor:
David A. Russler-Germain, Ramzi Abboud, Thomas J Fountaine, Eric Huselton, Jeffrey R. Andolina, Luke Eastburg, John F. DiPersio
Publikováno v:
Leukemia & Lymphoma. 63:222-226
Due to the evolving use of haploidentical donor grafts in hematopoietic cell transplantation, there is increased need to better understand the risks and benefits of using bone marrow versus peripheral blood grafts, as well as how specific pre-transpl
Autor:
Jeffrey Andolina, Myra Coppage, Andrea Baran, Luke Eastburg, Carol Fries, Craig Mullen, Tate Feeney, Jane Liesveld, Michael Becker, Omar Aljitawi, Eric Huselton
Publikováno v:
Transplantation and Cellular Therapy. 28:S364-S365
Autor:
Luke Eastburg, David Russler-Germain, John DiPersio, Thomas Fountaine, Jeffrey Andolina, Ramzi Abboud, Eric Huselton
Due to the evolving use of haploidentical donor grafts in hematopoietic cell transplantation, there is increased need to better understand the risks and benefits of using bone marrow versus peripheral blood grafts, as well as how specific pre-transpl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::04a441d3b1e83b5c9f67fc84354f8c01
https://doi.org/10.21203/rs.3.rs-378419/v1
https://doi.org/10.21203/rs.3.rs-378419/v1
Publikováno v:
The American Journal of Medicine. 131:1317-1320
Autor:
Bwire Chirangi, Esther Kawira, Brian Dee Akungo, Luke Eastburg, Emmanuela E. Ambrose, Andrew Peckham, Luke R. Smart, David H. Adler
Publikováno v:
Pediatr Blood Cancer
BACKGROUND/OBJECTIVES: Sickle cell disease (SCD) is an important, hidden cause of childhood mortality worldwide. It is most prevalent in sub-Saharan Africa where national newborn screening programs remain unavailable and most children in rural areas
Autor:
Omar S. Aljitawi, Thomas J Fountaine, Luke Eastburg, Peter Westervelt, Ramzi Abboud, David A. Russler-Germain, Michael W. Becker, John F. DiPersio, Jane L. Liesveld, Eric Huselton, Jeffrey R. Andolina, Neha Kumar
Publikováno v:
Blood. 134:4496-4496
The use of post-transplant cyclophosphamide (PTCy) in the context of haploidentical stem cell transplant (haplo-SCT) has led to drastically reduced rates of Graft-vs-Host (GvH) disease through selective depletion of highly allo-reactive donor T-cells